$163.11
0.16% today
NYSE, Mar 13, 06:45 pm CET
ISIN
US4781601046
Symbol
JNJ

Johnson & Johnson Stock price

$162.85
+7.59 4.89% 1M
-1.79 1.09% 6M
+18.23 12.61% YTD
+0.11 0.07% 1Y
-8.84 5.15% 3Y
+37.44 29.85% 5Y
+63.02 63.13% 10Y
NYSE, Closing price Wed, Mar 12 2025
-3.01 1.81%
ISIN
US4781601046
Symbol
JNJ
Sector
Industry

Key metrics

Market capitalization $392.08b
Enterprise Value $405.39b
P/E (TTM) P/E ratio 28.09
EV/FCF (TTM) EV/FCF 20.43
EV/Sales (TTM) EV/Sales 4.56
P/S ratio (TTM) P/S ratio 4.41
P/B ratio (TTM) P/B ratio 5.48
Dividend yield 3.02%
Last dividend (FY24) $4.91
Revenue growth (TTM) Revenue growth -4.51%
Revenue (TTM) Revenue $88.82b
EBIT (operating result TTM) EBIT $20.89b
Free Cash Flow (TTM) Free Cash Flow $19.84b
Cash position $24.52b
EPS (TTM) EPS $5.80
P/E forward 17.49
P/S forward 4.36
EV/Sales forward 4.51
Short interest 0.96%
Show more

Create a Free Account to create an Johnson & Johnson alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Johnson & Johnson Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Johnson & Johnson forecast:

11x Buy
48%
12x Hold
52%

Analyst Opinions

23 Analysts have issued a Johnson & Johnson forecast:

Buy
48%
Hold
52%

Financial data from Johnson & Johnson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
88,819 88,819
5% 5%
100%
- Direct Costs 27,792 27,792
7% 7%
31%
61,027 61,027
3% 3%
69%
- Selling and Administrative Expenses 15,530 15,530
6% 6%
17%
- Research and Development Expense 17,265 17,265
13% 13%
19%
28,232 28,232
10% 10%
32%
- Depreciation and Amortization 7,339 7,339
2% 2%
8%
EBIT (Operating Income) EBIT 20,893 20,893
12% 12%
24%
Net Profit 14,066 14,066
1% 1%
16%

In millions USD.

Don't miss a Thing! We will send you all news about Johnson & Johnson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Johnson & Johnson Stock News

Neutral
24/7 Wall Street
about 22 hours ago
Market volatility can be unsettling for any investor.
Neutral
Reuters
one day ago
U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, with both citing increased threats after a UnitedHealth insurance executive was murdered outside the company's investor meeting in December, regulatory filings show.
Neutral
Business Wire
one day ago
DALLAS--(BUSINESS WIRE)--Leading plaintiff trial firm Dean Omar Branham Shirley, LLP is pleased to announce the selection of partners Jessica Dean, Amin Omar, Trey Branham, Lisa Shirley, Ben Braly and attorney Mark Linder to the list of Lawdragon's 500 Leading Plaintiff Consumer Lawyers for 2025. The annual listing describes this year's honorees as “coast-to-coast champions who dedicate their l...
More Johnson & Johnson News

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Head office United States
CEO Joaquin Duato
Employees 138,100
Founded 1887
Website www.jnj.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today